Page last updated: 2024-11-02

oxybutynin and Cancer of Pancreas

oxybutynin has been researched along with Cancer of Pancreas in 2 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Research Excerpts

ExcerptRelevanceReference
"To obtain improved efficacy against pancreatic cancer, we investigated the efficacy and safety of a locally-applied 5-fluorouracil (5-FU)-loaded polymeric patch on pancreatic tumors in an orthotopic nude-mouse model."1.46Locally-applied 5-fluorouracil-loaded slow-release patch prevents pancreatic cancer growth in an orthotopic mouse model. ( Cho, DW; Choi, YJ; Hoffman, RM; Jeong, SY; Jun, E; Kim, SC; Lee, CM; Lee, YN; Shim, IK; Yi, HG; Yi, HJ, 2017)
"Pancreatic cancer has a high rate of local recurrence and poor prognosis even with adjuvant chemotherapy after curative resection."1.46Synergistic effect of a drug loaded electrospun patch and systemic chemotherapy in pancreatic cancer xenograft. ( Jun, E; Kim, SC; Lee, CM; Lee, S; Oh, J; Shim, IK, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shim, IK2
Yi, HJ1
Yi, HG1
Lee, CM2
Lee, YN1
Choi, YJ1
Jeong, SY1
Jun, E2
Hoffman, RM1
Cho, DW1
Kim, SC2
Oh, J1
Lee, S1

Other Studies

2 other studies available for oxybutynin and Cancer of Pancreas

ArticleYear
Locally-applied 5-fluorouracil-loaded slow-release patch prevents pancreatic cancer growth in an orthotopic mouse model.
    Oncotarget, 2017, Jun-20, Volume: 8, Issue:25

    Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Drug Liberation; Fluorouracil; Humans; M

2017
Synergistic effect of a drug loaded electrospun patch and systemic chemotherapy in pancreatic cancer xenograft.
    Scientific reports, 2017, 09-28, Volume: 7, Issue:1

    Topics: Administration, Cutaneous; Animals; Antineoplastic Combined Chemotherapy Protocols; Biocompatible Ma

2017